Biogen (BIIB) News Today $133.18 +3.11 (+2.39%) As of 12:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIIB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment?July 1 at 12:34 PM | tipranks.comProvident Co of the Employees of the Hebrew University LTD Boosts Holdings in Biogen Inc. (NASDAQ:BIIB)July 1 at 8:48 AM | marketbeat.comSumitomo Mitsui Trust Group Inc. Acquires 25,464 Shares of Biogen Inc. (NASDAQ:BIIB)July 1 at 4:49 AM | marketbeat.comMirae Asset Global Investments Co. Ltd. Acquires 7,531 Shares of Biogen Inc. (NASDAQ:BIIB)July 1 at 4:34 AM | marketbeat.comBiogen Inc.: Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous NephropathyJune 30 at 5:42 PM | finanznachrichten.deRBC says Lilly could blaze trail and Biogen could pull ahead in Alzheimer’s marketJune 30 at 5:42 PM | finance.yahoo.comBiogen Initiates Global Phase 3 PROMINENT Study for Felzartamab in Adults with Primary Membranous Nephropathy (PMN)June 30 at 8:14 AM | quiverquant.comQBiogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous NephropathyJune 30 at 7:47 AM | financialpost.comFBiogen Initiates Phase 3 Study of Felzartamab for the Treatment of Primary Membranous NephropathyJune 30 at 7:30 AM | globenewswire.comBiogen highlights ‘promising’ results for higher-dose nusinersen in SMA trialsJune 28, 2025 | finance.yahoo.comJ. L. Bainbridge & Co. Inc. Buys 26,539 Shares of Biogen Inc. (NASDAQ:BIIB)June 28, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Money Concepts Capital CorpJune 28, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Bought by Asset Management One Co. Ltd.June 28, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Has $2.61 Million Stake in Biogen Inc. (NASDAQ:BIIB)June 28, 2025 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Biogen (NASDAQ:BIIB)June 28, 2025 | americanbankingnews.comNew Data for Nusinersen Underscore Biogen's Commitment to Advancing Clinical Research to ...June 27, 2025 | gurufocus.comBiogen (BIIB) Highlights Promising Data on Nusinersen for SMA Treatment | BIIB Stock NewsJune 27, 2025 | gurufocus.comBiogen Inc. Reports Positive Findings from DEVOTE and NURTURE Studies on Higher Dose Regimen of Nusinersen for Spinal Muscular AtrophyJune 27, 2025 | quiverquant.comQNew Data for Nusinersen Underscore Biogen’s Commitment to Advancing Clinical Research to Improve Outcomes in SMAJune 27, 2025 | financialpost.comFNew Data for Nusinersen Underscore Biogen's Commitment to Advancing Clinical Research to Improve Outcomes in SMAJune 27, 2025 | globenewswire.comOld North State Wealth Management LLC Raises Position in Biogen Inc. (NASDAQ:BIIB)June 27, 2025 | marketbeat.comRobeco Institutional Asset Management B.V. Acquires 45,253 Shares of Biogen Inc. (NASDAQ:BIIB)June 27, 2025 | marketbeat.comWells Fargo Remains a Hold on Biogen (BIIB)June 27, 2025 | theglobeandmail.com5 Revealing Analyst Questions From Biogen’s Q1 Earnings CallJune 26, 2025 | msn.comBiogen (NASDAQ:BIIB) Receives "Buy" Rating from HC WainwrightJune 26, 2025 | marketbeat.comJanney Montgomery Scott LLC Purchases 5,620 Shares of Biogen Inc. (NASDAQ:BIIB)June 26, 2025 | marketbeat.comBiogen (NASDAQ:BIIB) Stock Price Expected to Rise, Royal Bank Of Canada Analyst SaysJune 26, 2025 | americanbankingnews.comBiogen’s Friedreich’s Ataxia Campaigns Earn 4 Cannes Lions Pharma NominationsJune 25, 2025 | insidermonkey.comBiogen-Ionis Partnered Drug Shows Benefit In Children With Spinal Muscular Atrophy Previously Treated With Novartis' ZolgensmaJune 25, 2025 | benzinga.comBiogen (BIIB) Advances SMA Treatment to Key Study Phase | BIIB Stock NewsJune 25, 2025 | gurufocus.comCan Biogen Outdo Its Own Spinal Muscular Atrophy Drug?June 25, 2025 | msn.comBiogen’s salanersen shows promise in SMA, heads toward registrational trialsJune 25, 2025 | msn.comGiant Biogene’s Controlling Shareholder Increases StakeJune 25, 2025 | tipranks.comBiogen (NASDAQ:BIIB) Price Target Raised to $213.00 at Royal Bank Of CanadaJune 25, 2025 | marketbeat.comArlington Partners LLC Acquires New Stake in Biogen Inc. (NASDAQ:BIIB)June 25, 2025 | marketbeat.comBiogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 ResultsJune 25, 2025 | globenewswire.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Kentucky Retirement Systems Insurance Trust FundJune 25, 2025 | marketbeat.comAnalysts Set Biogen Inc. (NASDAQ:BIIB) PT at $188.19June 25, 2025 | americanbankingnews.comKirr Marbach & Co. LLC IN Purchases 3,646 Shares of Biogen Inc. (NASDAQ:BIIB)June 24, 2025 | marketbeat.comBiogen Inc. (BIIB) Announces Results of 2025 Annual Meeting of StockholdersJune 23, 2025 | gurufocus.comBiogen Launches Phase 3 Pediatric Trial Of Omaveloxolone For Friedreich Ataxia.June 23, 2025 | msn.comBiogen: Investors Are Missing The Bigger PictureJune 22, 2025 | seekingalpha.comBiogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of "Hold" by BrokeragesJune 22, 2025 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Bought by North Growth Management Ltd.June 21, 2025 | marketbeat.comLilly to appeal as U.K. declines to endorse use of new Alzheimer’s drugsJune 20, 2025 | msn.comCWA Asset Management Group LLC Invests $3.08 Million in Biogen Inc. (NASDAQ:BIIB)June 19, 2025 | marketbeat.comBiogen Dips on Its Part in BRAVE StudyJune 18, 2025 | baystreet.caBiogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich AtaxiaJune 18, 2025 | globenewswire.comBiogen Targets Rare Diseases, Eyes $800M Cost Cuts With ‘Fit for Growth’ PlanJune 17, 2025 | msn.comBiogen (BIIB) Considers Bid Amid Sage Therapeutics Merger Developments | BIIB Stock NewsJune 17, 2025 | gurufocus.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.910.89▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼3423▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Today Gilead Sciences News Today Ionis Pharmaceuticals News Today Moderna News Today Prothena News Today Sage Therapeutics News Today Cassava Sciences News Today Vertex Pharmaceuticals News Today Bristol Myers Squibb News Today Eli Lilly and Company News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIIB Stock Alerts